Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PMS Assessing the Safety and Efficacy of Telmisartan in Patients With Mild-to-moderate Essential Hypertension

NCT00638911 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00638911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00638911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PMS Assessing the Safety and Efficacy of Telmisartan in Patients With Mild-to-moderate Essential Hypertension
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
September 30, 2004
Completion date
Not reported
Enrollment
33,247 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension